Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation, Summary of Significant Accounting Policies and Nature of Operations (Narrative) (Details)

v3.5.0.2
Basis of Presentation, Summary of Significant Accounting Policies and Nature of Operations (Narrative) (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 20, 2016
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Dec. 31, 2015
Aug. 02, 2016
Dec. 31, 2014
Stockholders' Deficit   $ 1,103,170   $ 1,103,170   $ (1,499,068)    
Retained Earnings (Accumulated Deficit)   (76,003,352)   $ (76,003,352)   (74,371,441)    
Operating cycle length - Westinghouse-type       24 months        
Cash and Cash Equivalents, at Carrying Value   1,484,099 $ 2,371,266 $ 1,484,099 $ 2,371,266 $ 623,184   $ 4,220,225
Research and Development Expense   $ 419,498 $ 394,715 $ 1,005,748 $ 607,545      
Stockholders' Equity, Reverse Stock Split 1 for 5              
Common Stock, Shares, Issued and Outstanding   4,799,906   4,799,906   3,725,819    
Common Stock, Shares Authorized   100,000,000   100,000,000   100,000,000    
Preferred Stock, Shares Authorized   10,000,000   10,000,000   10,000,000    
Common Stock, Par or Stated Value Per Share   $ 0.001   $ 0.001   $ 0.001    
Preferred Stock, Par or Stated Value Per Share   $ 0.001   $ 0.001   $ 0.001    
Aspire Capital [Member]                
Equity Agreement, Amount   $ 20,000,000   $ 20,000,000        
Series A Preferred Stock [Member]                
Convertible Preferred Stock Amount             $ 2,800,000  
Reverse Stock Split [Member]                
Common Stock, Par or Stated Value Per Share   $ 0.001   $ 0.001        
Preferred Stock, Par or Stated Value Per Share   $ 0.001   $ 0.001        
Minimum [Member]                
Metallic fuel power uprate percentage       10.00%        
Amortization period for patents       17 years        
Minimum [Member] | Reverse Stock Split [Member]                
Common Stock, Shares, Issued and Outstanding   4,799,906   4,799,906   3,725,819    
Common Stock, Shares Authorized           100,000,000    
Preferred Stock, Shares Authorized           10,000,000    
Maximum [Member]                
Amortization period for patents       20 years        
Maximum [Member] | Reverse Stock Split [Member]                
Common Stock, Shares, Issued and Outstanding   23,999,386   23,999,386   18,628,957    
Common Stock, Shares Authorized   500,000,000   500,000,000        
Preferred Stock, Shares Authorized   50,000,000   50,000,000        
Approximations [Member]                
Working Capital       $ 400,000   $ 100,000    
Stockholders' Deficit   $ 1,100,000   1,100,000   1,500,000    
Cash   1,500,000   1,500,000   900,000    
Retained Earnings (Accumulated Deficit)   76,000,000   76,000,000   74,000,000    
Approximations [Member] | ENEC and FANR Projects [Member]                
Concentration Risk, Percentage     6.00%   22.00%      
Approximations [Member]                
Federally insured cash limit   250,000   250,000        
Cash and Cash Equivalents, at Carrying Value   1,500,000   1,500,000   600,000    
Restricted Cash   $ 0   $ 0   $ 300,000    
Concentration Risk, Percentage       99.00%   77.00%    
Approximations [Member] | ENEC and FANR Projects [Member]                
Concentration Risk, Percentage   6.00%       22.00%    
Approximations [Member] | Customer Contract [Member]                
Concentration Risk, Percentage   50.00%   21.00%        
Approximations [Member] | Vendor 1 [Member]                
Concentration Risk, Accounts Payable Percentage       63.00%   50.00%    
Approximations [Member] | Vendor 2 [Member]                
Concentration Risk, Accounts Payable Percentage       21.00%        
Approximations [Member] | United States Customer [Member]                
Concentration Risk, Percentage   43.00%   57.00%        
Joint Venture [Member] | Approximations [Member]                
Amount to be Paid Toward Total Cost of Work       $ 141,000        
Terms of Joint Venture       The total amount is due and payable by the Company as follows: 40% of the total amount due upon the effective date of the signing of the JD; 30% of the total amount due upon the delivery of an intermediate report by AREVA and the remaining 30% due upon the delivery of the final report to the Company.        
Initial Payment Included in Accounts Payable       $ 58,000